60 Degrees Pharmaceuticals, Inc.
SXTP· Nasdaq
Released Aug 14, 2026, during market hours
10-Q filed Aug 14, 2026, 45 days after period end · 0001554855-26-001860
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $207.90K | $100.93K | $124.97K | $59.53K |
| Net Income | -$2.26M | -$1.73M | -$4.17M | -$3.34M |
| EPS Diluted | -$0.90 |
60 Degrees Pharmaceuticals, Inc. · CIK 1946563 · Engraved from SEC EDGAR
| -$5.01 |
| -$21.12 |
| -$16.84 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.